Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
Hoffman
Jerome R
JR
D002543:Cerebral Hemorrhage / Q000139:chemically induced; D003675:Defensive Medicine; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator